Grant
In Vivo Validation of P2Y2 and P2Y14 Receptor Inhibition as a Therapeutic Strategy for the Treatment of Chronic Fatty Liver Disease
In Vivo Validation of P2Y2 and P2Y14 Receptor Inhibition as a Therapeutic Strategy for the Treatment of Chronic Fatty Liver Disease